Skip to content

Clinical trials

Shock, Cardiogenic trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Shock, Cardiogenic Country / region: Canada Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20171
20191
20212
20223
20231
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting3
Unknown status3
Completed2
Not yet recruiting2
Terminated2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ottawa Heart Institute Research Corporation4
Arginox Pharmaceuticals1
Filio Billia1
Laval University1
Mallinckrodt1
New Brunswick Heart Centre1
STAVROS G DRAKOS1
Saint-Louis Hospital, Paris, France1
University Health Network, Toronto1
University of Utah1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Shock, Cardiogenic13
Shock4
Acute Coronary Syndrome1
Cardiac Output, Low1
Edema1
Heart Arrest1
Heart Diseases1
Heart Failure1
Mitral Valve Insufficiency1
Myocardial Infarction1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.